Aethlon Medical (NASDAQ: AEMD) reported Q3 EPS of ($0.20), $0.04 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $624.87 thousand versus the consensus estimate of $100 thousand.

For earnings history and earnings-related data on Aethlon Medical (AEMD) click here.